Cargando…

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer

AIMS: Pelvic lymph node (PLN) radiotherapy for high-risk prostate cancer is limited by late gastrointestinal toxicity. Application of rectal and bowel constraints may reduce risks of side-effects. We evaluated associations between intensity-modulated radiotherapy (IMRT) dose-volume data and long-ter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira, M.R., Thomas, K., Truelove, L., Khan, A., Parker, C., Dearnaley, D.P., Gulliford, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505687/ https://www.ncbi.nlm.nih.gov/pubmed/30902559 http://dx.doi.org/10.1016/j.clon.2019.02.012

Ejemplares similares

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
por: Dearnaley, David, et al.
Publicado: (2019)

Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study
por: Ito, Makoto, et al.
Publicado: (2020)

Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity
por: Choo, Richard, et al.
Publicado: (2021)

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
por: Tsuchida, Keisuke, et al.
Publicado: (2020)

Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy
por: McDonald, Andrew M, et al.
Publicado: (2014)

Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer
por: Wilkins, Anna, et al.
Publicado: (2015)

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
por: Reis Ferreira, Miguel, et al.
Publicado: (2017)

Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma
por: Baker, Christopher B., et al.
Publicado: (2016)

Role of Pelvic Lymph Node Dissection in Prostate Cancer Treatment
por: Joung, Jae Young, et al.
Publicado: (2011)

Pelvic lymph node dissection in high-risk prostate cancer
por: Haiquel, Luciano, et al.
Publicado: (2021)

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
por: Naismith, O.F., et al.
Publicado: (2019)

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
por: Parker, C C, et al.
Publicado: (2002)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
por: Van Baelen, Anthony, et al.
Publicado: (2012)

Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT
por: Björeland, Ulrika, et al.
Publicado: (2018)

A narrative review of pelvic lymph node dissection in prostate cancer
por: Cheung, Douglas C., et al.
Publicado: (2020)

Impact of prostate focused alignment on planned pelvic lymph node dose
por: Kilian‐Meneghin, Joshua, et al.
Publicado: (2021)

Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial
por: Krause, Sonja, et al.
Publicado: (2012)

Haute Couture or Ready-To-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node Detection
por: Michaud, Anne-Victoire, et al.
Publicado: (2020)

Outcomes following external beam radiotherapy to the prostate and pelvic lymph nodes in addition to androgen deprivation therapy in non-metastatic prostate adenocarcinoma with regional lymph node involvement: a retrospective cohort study
por: Mohamad Roji, Akmal, et al.
Publicado: (2023)

Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer
por: Furubayashi, Nobuki, et al.
Publicado: (2020)

Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study
por: Ferreira, Miguel R., et al.
Publicado: (2021)

Helical intensity-modulated Radiotherapy of the Pelvic Lymph Nodes with Integrated Boost to the Prostate Bed - Initial Results of the PLATIN 3 Trial
por: Katayama, Sonja, et al.
Publicado: (2014)

MR imaging of pelvic lymph nodes
por: Barentsz, Jelle
Publicado: (2015)

Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
por: Osmonov, Daniar K., et al.
Publicado: (2014)

An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer
por: Groher, M., et al.
Publicado: (2017)

Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)
por: Stanley, S., et al.
Publicado: (2008)

The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients
por: Tsang, Yat Man, et al.
Publicado: (2017)

Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
por: Jansen, B. H. E., et al.
Publicado: (2020)

Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes
por: Hesselberg, Gina, et al.
Publicado: (2015)

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer
por: Lemanska, A., et al.
Publicado: (2018)

Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer
por: Lee, Jie, et al.
Publicado: (2023)

Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis
por: Chen, Junru, et al.
Publicado: (2020)

Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial
por: Habl, Gregor, et al.
Publicado: (2015)

CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients
por: Yousefi Kashi, Amir Shahram, et al.
Publicado: (2016)

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
por: Lyons, Ciara A., et al.
Publicado: (2017)

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

The role of radiotherapy in localised and locally advanced prostate cancer
por: Bolla, Michel, et al.
Publicado: (2019)

Pelvic lymph node dissection alone versus adjuvant radiotherapy in node positive penile cancer: A systematic review
por: Naushad, Naufa, et al.
Publicado: (2022)

MRI-guided pelvic lymph node biopsy via transrectal approach in prostate cancer
por: Hague, Christian, et al.
Publicado: (2020)

Impact of rotational errors of whole pelvis on the dose of prostate-based image-guided radiotherapy to pelvic lymph nodes and small bowel in high-risk prostate cancer
por: Katayama, Hiroki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t003fa5no003i91ctin2d5l8k2